OTUD5-SLC7A11 Axis Identified as Novel Target in AML Progression
OTUD5 promotes AML progression by stabilizing SLC7A11, suppressing ferroptosis and enhancing cell survival.
Asset / Drug
Drug and asset intelligence for OTUD5 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.